Geistlich Pharma North America, Inc., is an affiliate of Geistlich Pharma AG who produce and distribute medical devices and pharmaceuticals for regenerative medicine in Wolhusen and Root, Switzerland. The Swiss company forms part of the Geistlich group which has been in family hands since 1851. Geistlich Pharma and its 3 business units Geistlich Biomaterials, Geistlich Surgery, Geistlich Medical have 10 subsidiaries and global distribution, over 500 employees worldwide and is a world leader in regenerative dentistry through its business unit Geistlich Biomaterials. Geistlich continues to lead oral regeneration based upon our history of quality, scientific collaboration, and manufacturing excellence. Every Geistlich biomaterial is intentionally designed for a specific application and carefully engineered to preserve its natural structures. Today, our full product portfolio of Bone Substitutes, Membranes, and Matrices increases clinical flexibility and expands treatment options in a variety of therapeutic areas. Geistlich Bio-Oss: Derived from bovine bone and preserved through a unique, patented process, making it highly similar to human bone. Geistlich Bio-Oss remains the essential choice among an expanding range of therapeutic areas through its unique properties and reliable clinical outcomes. Geistlich Bio-Gide: A unique bilayer collagen membrane designed to ensure optimal regenerative healing of bone and soft tissue. It provides excellent wound stability and graft containment with optimal protection for bone regeneration. Geistlich Mucograft: A collagen matrix designed for gain of keratinized tissue and recession coverage where open healing is required. Geistlich Fibro-Gide: The first volume-stable collagen matrix designed for soft-tissue augmentation around natural teeth and implants as a submerged scaffold where an increase in soft-tissue thickness is clinically desired.